The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
Status:
Recruiting
Trial end date:
2024-08-08
Target enrollment:
Participant gender:
Summary
Objective propose: to investigate the effect of Ramipril in suppressing ST2 (suppression of
tumorigenicity 2) in the cardiac mitral valve in patients with Rheumatic Heart Disease. We
hypothesized that we hypothesized that ramipril will improve rheumatic mitral valve fibrosis
through the downregulation of ST2.